Varocha MahachaiRatha Korn VilaichoneRapat PittayanonJarin RojborwonwitayaSomchai LeelakusolvongChomsri KositchaiwatPisaln MairiangOng Ard PraisontarangkulBuncha OvartlarnpornJaksin SottisupornPises PisespongsaMonthira ManeerattanapornRavin SonySiam SirinthornpunyaOrawan ChaiyamahapurkOlarn WiwattanachangInchaya SansakPiyathida HarnsomboonTaned ChitapanaruxSurapon ChuenrattanakulChulalongkorn UniversityThammasat University HospitalMahidol UniversityKhon Kaen UniversityChiang Mai UniversityNKC institute of Gastroenterology and HepatologyLampang HospitalRajavithi HospitalBuddhachinaraj HospitalUdonthani HospitalPhramongkutklao College of MedicineNational Gastric Cancer and Gastrointestinal Diseases Research Center2018-12-112019-03-142018-12-112019-03-142016-06-01Asian Pacific Journal of Cancer Prevention. Vol.17, No.5 (2016), 2351-23602476762X151373682-s2.0-84974625929https://repository.li.mahidol.ac.th/handle/20.500.14594/43027Management of Helicobacter pylori infection is an important aspect of many upper gastrointestinal tract diseases, such as chronic gastritis, peptic ulcer disease, gastric cancer and mucosa-associated lymphoid tissue (MALT) lymphoma. The Thailand Consensus on H. pylori treatment 2015 consisted of 22 national experts who took active roles, discussed all important clinical information and investigated clinical aspects in four workshops, focuising on: (1) Diagnosis (2) Treatment (3) Follow-up after eradication and (4) H. pylori infection and special conditions. Experts were invited to participate on the basis of their expertise and contribution to H. pylori works and/or consensus methodology. The results of each workshop were taken to a final consensus vote by all experts. Recommendations were developed from the best evidence and availability to guide clinicians in management of this specific infection associated with variety of clinical outcomes.Mahidol UniversityBiochemistry, Genetics and Molecular BiologyReviewSCOPUS10.7314/APJCP.2016.17.5.2351